Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Text with EEA relevance)
32024R1860 · 2 watched acts amended · in 4 events
on EUR-Lex
in force 2025-01-10
02017R0746-20240709 → 02017R0746-20250110
Amended by Regulation (EU) 2024/1860 32024R1860
detected 2026-08-12
5 provisions touched — 5 substantive, 0 date-only, 4 disputed · 4 changes without an explanation
Every change in this event, with the text before and after →
Attributed to this instrument: Art. 10a, Art. 74, Art. 110, Art. 112, Art. 113
in force 2024-07-09
02017R0746-20230320 → 02017R0746-20240709
Amended by Regulation (EU) 2024/1860 32024R1860
detected 2026-08-12
5 provisions touched — 5 substantive, 0 date-only, 1 disputed · 1 change without an explanation
Every change in this event, with the text before and after →
Attributed to this instrument: Art. 10a, Art. 74, Art. 110, Art. 112, Art. 113
in force 2025-01-10
02017R0745-20240709 → 02017R0745-20250110
Amended by Regulation (EU) 2024/1860 32024R1860 · Regulation (EU) 2024/568 32024R0568
in force 2025-01-01, 2025-01-10 · detected 2026-08-12
2 provisions touched — 2 substantive, 0 date-only, 0 disputed · every change carries an explanation that passed its citation check
Every change in this event, with the text before and after →
Attributed to this instrument: Art. 10a
in force 2024-07-09
02017R0745-20230320 → 02017R0745-20240709
Amended by Regulation (EU) 2024/1860 32024R1860
detected 2026-08-12
6 provisions touched — 6 substantive, 0 date-only, 1 disputed · 1 change without an explanation
Every change in this event, with the text before and after →
Attributed to this instrument: Art. 10a, Art. 34, Art. 78, Art. 120, Art. 122, Art. 123